Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | FMPV-1 + Sargramostim |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| FMPV-1 | FMPV 1|FMPV1 | FMPV-1 is a synthetic peptide derived from frameshift-mutated TGFRB2, which potentially induces expansion of T-lymphocytes and antitumor immune response (PMID: 39998682). | ||
| Sargramostim | Leukine | GM-CSF|Prokine |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05238558 | Phase I | FMPV-1 + Sargramostim | Safety and Immune Response to FMPV-1 | Completed | GBR | 0 |